ABOUT | Our Company
Established in 2015 by Dr. Lena Dobson, ScandicNeuro Corp (SNC) is dedicated to neuropsychology consultation and research. The company provides services to diverse enterprises participating in global clinical trials research and is actively involved in a diverse range of clinical trials, covering areas such as dementias, Mild Cognitive Impairment, brain injury, depression, schizophrenia, interventions, and virtual assessments. All services are available in both English and Swedish.
Our expertise in neuropsychology and clinical research position us as a valuable partner for organizations involved in various phases of clinical trial research. Whether it’s consultation, research support, or other related services, SNC is committed to contributing to the success of the clinical trial. For more details on how we can assist your company, please explore the relevant sections on our website or reach out to us directly.
SNC conducts independent clinical research and engages in product/software development within the field of neuropsychology. Additionally, we collaborate with startups, non-profits, and other enterprises on joint research initiatives.
ABOUT | Dr. Dobson
Dr. Lena Dobson earned her Ph.D. in clinical psychology (neuropsychology concentration) from APA-accredited Nova Southeastern University. While completing her Ph.D., Dr. Dobson was the Primary Investigator for a 6-year longitudinal research study focused on neuropsychological measures and sports concussion in professional baseball. She completed a two-year postdoctoral fellowship in clinical neuropsychology focused on traumatic brain injury. Dr. Dobson founded ScandicNeuro Corp, a consulting and research corporation, in 2015. The company consults in global clinical trials and conducts independent research.
Dr. Dobson has written articles for peer-reviewed medical journals, co-authored books, and presented her work at international and domestic conferences. She is an Editorial Board member for Journal of Veterans Studies and the International Neuropsychological Society’s (INS) INS Newsletter. Dr. Dobson is a peer reviewer for several medical journals, including Frontier in Psychiatry, Applied Neuropsychology, and Neuropsychology Review. In her 2018 TEDx talk titled “Good Information is the Foundation of Good Care,” she discussed her company’s mission to enhance public access to high-quality mental health information.
Being passionate about global connectivity and collaboration, Dr. Dobson is the Chair of the INS Science Committee. She serves as a Program Committee Member for INS and American Psychological Association (APA) conferences. Dr. Dobson was a Chair of the INS Brain Injury Special Interest Group (2019-2023) and the INS Special Interest Group Liaison (2017-2020). Additionally, Dr. Dobson is a member of several other professional organizations, including INS, APA, Society of Clinical Neuropsychology (SCN); Swedish Neuropsychological Association (SNPF), and the International Society for CNS Clinical Trials and Methodology (ISCTM).
Dr. Dobson is a certified Continued Education-instructor (ID 1344701) in the state of Florida. She is a licensed foster parent, a Guardian Ad Litem for the 15th Judicial Circuit, and a Surrogate Parent for Education for children in the foster care system.
Every year, 42.5 million of the adult US population suffer from mental illness. When living with a mental illness or caring for an individual diagnosed with mental illness, having access to accurate and reliable information is key. There is a need for technology that allows patients, caretakers, and advocates to gain greater control of their situation. Information is power while lack thereof, leaves a sense of being powerless no matter the age, disorder, or situation. This technology already exists and benefits patients with physical illness, so isn’t it time for patients with mental illness to have similar benefits?
